Goldman Sachs’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.28M | Sell |
|
|||||
|
2025
Q1 | $3.13M | Sell |
|
|||||
|
2024
Q4 | $8.79M | Sell |
|
|||||
|
2024
Q3 | $16.9M | Buy |
|
|||||
|
2024
Q2 | $3.01M | Buy |
|
|||||
|
2024
Q1 | $1.73M | Sell |
|
|||||
|
2023
Q4 | $1.32M | Sell |
|
|||||
|
2023
Q3 | $2.41M | Buy |
|
|||||
|
2023
Q2 | $2.02M | Sell |
|
|||||
|
2023
Q1 | $5.29M | Sell |
|
|||||
|
2022
Q4 | $13.8M | Buy |
|
|||||
|
2022
Q3 | $9.69M | Buy |
|
|||||
|
2022
Q2 | $9.24M | Buy |
|
|||||
|
2022
Q1 | $10M | Sell |
|
|||||
|
2021
Q4 | $13.2M | Buy |
|
|||||
|
2021
Q3 | $5.88M | Sell |
|
|||||
|
2021
Q2 | $5.72M | Buy |
|
|||||
|
2021
Q1 | $4.64M | Buy |
|
|||||
|
2020
Q4 | $2.43M | Buy |
|